Table III.
Reasons for discontinuation of the biologic treatment
| Reason for discontinuation | Prescriptions (n = 127) |
|---|---|
| Lost to follow-up or because of COVID-19 pandemic restrictions, no. (%) | 41 (32.3) |
| Lack of response, no. (%)∗ | 39 (30.7) |
| Side effects, no. (%) | 14 (11) |
| Patient preference, no. (%) | 14 (11) |
| Inadequate insurance coverage, no. (%) | 11 (8.7) |
| Noncompliance, no. (%) | 8 (6.3) |
Defined as the need for prednisone taper for treatment of asthma exacerbations while compliant with a biologic.